Who is sponsoring NCT05138341?

NCT05138341 is sponsored by The Ottawa Hospital.

What drugs are being tested in NCT05138341?

Interventions in NCT05138341: Minimally invasive surgical (MIS) intracranial hemorrhage Evacuation.

What condition does NCT05138341 study?

NCT05138341 studies Intracranial Hemorrhages.

Is NCT05138341 still recruiting?

NCT05138341 is currently status unknown. Last updated 3 November 2023.

Last reviewed 2023-11-03 · How we verify

NCT05138341: HEALME

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Minimal Invasive Surgical Intracerebral Hemorrhage Removal

Status unknown NA Last updated 3 November 2023

What this trial tests

NA trial testing Minimally invasive surgical (MIS) intracranial hemorrhage Evacuation in Intracranial Hemorrhages in 16 participants. Status unknown.

Timeline

1 November 2024

Primary endpoint
31 December 2025

31 December 2025

Quick facts

Lead sponsor	The Ottawa Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	16
Start date	1 November 2024
Primary completion	31 December 2025
Estimated completion	31 December 2025

Drugs / interventions tested

Minimally invasive surgical (MIS) intracranial hemorrhage Evacuation

Conditions studied

Intracranial Hemorrhages — all drugs for Intracranial Hemorrhages →

Sponsor

The Ottawa Hospital

Who can join

18 and older, any sex, with Intracranial Hemorrhages. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a feasibility study trial to determine whether hyperacute (≤8 hour) mechanical Minimal Invasive Surgical (MIS) management is feasible and secondarily improves outcome in patients with spontaneous supratentorial intracranial hemorrhage (ICH). Patients meeting the inclusion and exclusion criteria, will be enrolled and randomized to either minimally invasive hematoma evacuation (MIS) or best medical management alone (MM). Subjects will be randomly assigned by a central web-based system in a 3:1 manner to treatment with MIS or MM. Data for each subject will be collected at the time of enrollment and treatment, and at subsequent follow-up visits.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Surgery for spontaneous supratentorial intracerebral haemorrhage.
Wilting FN, Sondag L, Schreuder FH, Dammers R, et al · · 2025 · cited 5× · PMID 40673401 · DOI 10.1002/14651858.cd015387.pub2
The potential for minimally invasive intracerebral hemorrhage evacuation in routine healthcare: applicability of the ENRICH trial criteria to an unselected cohort.
Apostolaki-Hansson T, Hillal A, Göransson N, Hansen BM, et al · · 2024 · PMID 41542253 · DOI 10.3389/fstro.2024.1403812

Verify or expand the search:

Other recruiting trials for Intracranial Hemorrhages

Currently open trials in the same condition.

NCT06878066 — Thrombolysis in Factor Xa-inhibitors Trial · Phase 3 · recruiting
NCT07175519 — Safety and Efficacy of Aneurysms Treated With Endovascular Devices · recruiting
NCT06632587 — Timing Impact of Early vs. Late Cranioplasty on Hemicraniectomy Outcomes · NA · recruiting
NCT06635564 — Personalized ViscoElastic Testing-guided Bleeding Management In Liver Surgery, Neurosurgery and Obstetrics · recruiting
NCT06404645 — A Clinical Prospective Observational Study of Near Infrared Spectroscopy to Detect Subcranial Hematoma · recruiting

Other The Ottawa Hospital trials

Trials by the same sponsor.

NCT05794113 — Comparing the Use of a Mobile App for Surveillance of Adverse Events Following Influenza Immunization to a Web-Based Pla · NA · completed
NCT04136496 — Evaluation of a Novel Axillary Lymph Node Ink Localization Technique: A Feasibility Study · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05138341 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Ottawa Hospital
Last refreshed: 3 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05138341.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing